Seagen stockholders approve acquisition by pfizer

Bothell, wash.--(business wire)--following a special meeting of its stockholders, seagen inc. (nasdaq: sgen) today announced that its stockholders voted to approve a proposal to adopt the previously announced merger agreement under which pfizer will acquire seagen for $229 per share in cash. more than 99% of the shares voted at the meeting, representing approximately 88% of the shares of seagen common stock issued and outstanding as of the record date for the special meeting, were voted in favo.
SGEN Ratings Summary
SGEN Quant Ranking